Filing Flows › Repligen (RGEN) › Q3 2026
Repligen (RGEN) Q3 2026 earnings results (third quarter 2026)
10-Q filed Oct 30, 2026
Repligen (RGEN) reported revenue of $209M for the third quarter 2026 (Q3 2026), +11% from a year earlier and +3% from the quarter before. Operating margin was -14.1%, net loss $38.4M (18.4% of revenue).
Repligen, Q3 2026: revenue $209M (+11% year over year), operating margin -14.1%, net loss $38.4M, operating cash flow $43.1M. The chart follows the revenue to costs, profit and cash.
| Q3 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $209M | +3% | +11% |
| Operating profit | −$29.5M | -311% | -276% |
| Net earnings | −$38.4M | -867% | -358% |
| Operating cash flow | $43.1M | +32% | -10% |
| Free cash flow | $38.2M | +39% | -12% |
What changed
Revenue was $209.3M in Q3 2026, up 11% year over year and up 3% from the previous quarter. Product was the largest line at 100% of revenue. Product added $20.5M year over year (up 11%), 100% of the total change.
Operating costs exceeded revenue by $29.5M, an operating margin of -14.1%. Total costs grew 39% against revenue growth of 11%. The quarter ended with a net loss of $38.4M, after a profit of $5.0M the previous quarter.
Operating cash flow was $43.1M (down 10% year over year). Non-cash charges added back $19.1M of depreciation and amortization and $9.4M of share-based compensation. Working capital and other items added $53.1M. Capital expenditures of $4.9M left free cash flow of $38.2M.
Questions
What was Repligen's revenue in the third quarter 2026?
Repligen (RGEN) reported revenue of $209M for the third quarter 2026 (Q3 2026), +11% from a year earlier and +3% from the quarter before.
Was Repligen profitable in the third quarter 2026?
Operating loss was $29.5M (-14.1% of revenue) and net loss $38.4M.
Source: Repligen 10-Q on SEC EDGAR.